Literature DB >> 7833467

Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue.

S Iwamoto1, T Omi, E Kajii, S Ikemoto.   

Abstract

The Duffy blood group antigen has been characterized by its roles on red blood cells: as a receptor for the malarial parasites and as a promiscuous receptor for chemokine superfamily. Recently, the Duffy blood group associated glycoprotein D (gpFy) cDNA has been cloned (Chaudhuri et al: Proc Natl Acad Sci USA 90:10793, 1993). In this report we describe the organization of genomic DNA coding for the gpFy and elucidate the molecular nature of Fya/b polymorphisms. By a Southern blotting analysis probed with gpFy cDNA, gpFy gene was shown to be composed of three DNA fragments; 1.1-kb Sac I, 1.9-kb EcoRI, and their intervening 47-bp fragments. We cloned the 1.1-kb Sac I and 1.9-kb EcoRI fragments by inverted polymerase chain reaction (IPCR) procedure. The promoter region of the gpFy gene was cloned by IPCR of 1.1-kb Sac I fragment and the 3' flanking sequence was cloned by IPCR of 1.9 kb EcoRI fragment. The both IPCR products contained on both side the known gpFy cDNA sequence without introns, as expected. Although no TATA or CCAAT boxes are present in the promoter sequence, several transcription factor binding site motifs are contained, including AP-1, HNF-5, TCF-1, ApoE B2, W-element, H-APF-1, and Sp-1. The 3' flanking region has two additional polyadenylation signals, other than that used in the cDNA, and also has an indirect and a direct repeat sequence clustered with the 5' flanking region. These facts indicate a possibility that the gpFy gene has been evolved by multiple retrotransposition events. By comparing the coding area of the gpFy gene in 28 Duffy-positive individuals, we elucidated that one base change that results in an amino acid substitution [GA-T(Asp44)-->GGT(Gly)] is in accordance with the Fya/Fyb polymorphism. This fact proves that the gpFy cDNA and its gene described in this report encode the Duffy blood group system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7833467

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

Review 3.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

4.  Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets.

Authors:  Zeyu Xiong; John Cavaretta; Lirong Qu; Donna Beer Stolz; Darrell Triulzi; Janet S Lee
Journal:  Transfusion       Date:  2010-08-24       Impact factor: 3.157

5.  Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.

Authors:  Didier Ménard; Céline Barnadas; Christiane Bouchier; Cara Henry-Halldin; Laurie R Gray; Arsène Ratsimbasoa; Vincent Thonier; Jean-François Carod; Olivier Domarle; Yves Colin; Olivier Bertrand; Julien Picot; Christopher L King; Brian T Grimberg; Odile Mercereau-Puijalon; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

6.  Blood group genotyping in a population of highly diverse ancestry.

Authors:  J Pellegrino; L Castilho; M Rios; C A De Souza
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 7.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

8.  Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes.

Authors:  András N Spaan; Tamara Reyes-Robles; Cédric Badiou; Sylvie Cochet; Kristina M Boguslawski; Pauline Yoong; Christopher J Day; Carla J C de Haas; Kok P M van Kessel; François Vandenesch; Michael P Jennings; Caroline Le Van Kim; Yves Colin; Jos A G van Strijp; Thomas Henry; Victor J Torres
Journal:  Cell Host Microbe       Date:  2015-08-27       Impact factor: 21.023

9.  Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Authors:  Christophe Tournamille; Antoine Blancher; Caroline Le Van Kim; Pierre Gane; Pol André Apoil; Wilson Nakamoto; Jean Pierre Cartron; Yves Colin
Journal:  Immunogenetics       Date:  2004-01-08       Impact factor: 2.846

10.  Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.

Authors:  Renate B Schnabel; Jens Baumert; Maja Barbalic; Josée Dupuis; Patrick T Ellinor; Peter Durda; Abbas Dehghan; Joshua C Bis; Thomas Illig; Alanna C Morrison; Nancy S Jenny; John F Keaney; Christian Gieger; Cathy Tilley; Jennifer F Yamamoto; Natalie Khuseyinova; Gerardo Heiss; Margaret Doyle; Stefan Blankenberg; Christian Herder; Jeremy D Walston; Yanyan Zhu; Ramachandran S Vasan; Norman Klopp; Eric Boerwinkle; Martin G Larson; Bruce M Psaty; Annette Peters; Christie M Ballantyne; Jacqueline C M Witteman; Ron C Hoogeveen; Emelia J Benjamin; Wolfgang Koenig; Russell P Tracy
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.